Pee test could spot prostate cancer, no biopsy needed
NCT ID NCT04788277
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 38 times
Summary
This study is testing a new way to detect prostate cancer by looking at cells in a urine sample using a special optical imaging method. Researchers will collect urine from 675 men aged 50-75, including those with and without prostate cancer, to see how accurate the test is. If it works, it could offer a simple, non-invasive alternative to traditional biopsies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Thomas Jefferson University Hospital
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Urine sample collection and optical imaging test
What this could lead to
If successful, this could provide a simple, non-invasive urine test to detect prostate cancer, reducing the need for biopsies.
What could go wrong
This is an early-stage diagnostic study, not a treatment trial. The test may not be accurate enough to replace current methods, and results may not apply to all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.